Pharma Pulse 5/29/24: OpenAI Forms New Committee to Evaluate Safety/Security, Proposed FDA Rule Could Limit Pharmacy Compounding & more

Finding Hope with Clinical Trials

Nick Slack, CEO and chairman for START Center for Cancer Research, discusses the complications that patients have getting enrolled in clinical trials.

Proposed FDA Rule Could Limit Pharmacy Compounding

On March 20, 2024, the FDA proposed a new rule that would create criteria for certain drug products or categories that present “Demonstrable Difficulties for Compounding Lists”—known as DDC lists. The proposed rule is entitled “Drug Products or Categories of Drug Products That Present Demonstrable Difficulties for Compounding Under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act.”

OpenAI Forms New Committee to Evaluate Safety, Security

Move comes after firm became embroiled in a legal battle over a new voice assistant in its latest artificial-intelligence model.

Talkspace and Labcorp’s Ovia Health Form Women’s Health Coalition to Deliver Accessible, Affordable Solutions to Address Women's Diverse Health Needs

Conceive, Evernow, FitOn, Nurx, Cove, and Nutrium Join as Founding Members to Support the Coalition’s Focus on Expanding Access to Women-Centered Healthcare Resources in the Workplace.

Pharmaceutical Executive on LinkedIn:

Gear up for the highly anticipated Pharmaceutical Executive® APEX Awards making its grand return on November 14th in New York City!

Submit your work to a selection of 19 categories and celebrate this year’s best in the world of health care, pharma, and biopharma.

Enter now:https://ow.ly/kW0z50RTURB

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs